Andres Metspalu
Overview
Explore the profile of Andres Metspalu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
433
Citations
54555
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kals M, Reigo A, Teder-Laving M, Vaht M, Nikopensius T, Metspalu A, et al.
Mov Disord Clin Pract
. 2025 Feb;
PMID: 40019135
Background: Dopaminergic neuron depletion in the substantia nigra (SN) and the pathological aggregation of α-synuclein are the neuropathological hallmarks of Parkinson's disease (PD). Objectives: This study aimed to investigate the...
2.
Pezzullo A, Gris A, Scarsi N, Tona D, Porcelli M, Di Pumpo M, et al.
J Clin Epidemiol
. 2025 Feb;
:111729.
PMID: 39986491
Objective: Genetic and genomic tests are the cornerstone of personalized preventive approaches. Inconsistency in evaluating their clinical utility is often cited as a reason for their limited implementation in clinical...
3.
Trenkwalder T, Maj C, Al-Kassou B, Debiec R, Doppler S, Musameh M, et al.
JAMA Cardiol
. 2024 Nov;
10(2):145-154.
PMID: 39504041
Importance: Aortic stenosis (AS) and coronary artery disease (CAD) frequently coexist. However, it is unknown which genetic and cardiovascular risk factors might be AS-specific and which could be shared between...
4.
Sidorenko J, Couvy-Duchesne B, Kemper K, Moen G, Bhatta L, Asvold B, et al.
Nat Genet
. 2024 Oct;
56(11):2352-2360.
PMID: 39375568
Linkage studies have successfully mapped loci underlying monogenic disorders, but mostly failed when applied to common diseases. Conversely, genome-wide association studies (GWASs) have identified replicable associations between thousands of SNPs...
5.
Gustafsson S, Lampa E, Jensevik Eriksson K, Butterworth A, Elmstahl S, Engstrom G, et al.
Nat Cardiovasc Res
. 2024 Aug;
3(2):130-139.
PMID: 39196201
Myocardial infarction is a leading cause of death globally but is notoriously difficult to predict. We aimed to identify biomarkers of an imminent first myocardial infarction and design relevant prediction...
6.
Pajouheshnia R, Gini R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5871.
PMID: 39145406
Purpose: Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency-funded project (EUPAS39322), defined a set of metadata to describe real-world data sources (RWDSs) and...
7.
Gini R, Pajouheshnia R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5884.
PMID: 39145403
No abstract available.
8.
Schormair B, Zhao C, Bell S, Didriksen M, Nawaz M, Schandra N, et al.
Nat Genet
. 2024 Jun;
56(6):1090-1099.
PMID: 38839884
Restless legs syndrome (RLS) affects up to 10% of older adults. Their healthcare is impeded by delayed diagnosis and insufficient treatment. To advance disease prediction and find new entry points...
9.
Keaton J, Kamali Z, Xie T, Vaez A, Williams A, Goleva S, et al.
Nat Genet
. 2024 Apr;
56(5):778-791.
PMID: 38689001
Hypertension affects more than one billion people worldwide. Here we identify 113 novel loci, reporting a total of 2,103 independent genetic signals (P < 5 × 10) from the largest...
10.
Pastorino R, Pezzullo A, Osti T, Adany R, Borry P, Barnhoorn F, et al.
Eur J Cancer Prev
. 2024 Apr;
33(5):387-389.
PMID: 38598497
No abstract available.